Sign Up to like & get
recommendations!
1
Published in 2018 at "Clinical Cardiology"
DOI: 10.1002/clc.22942
Abstract: The treatment of coronary small vessel disease (SVD) remains an unresolved issue. Drug‐eluting stents (DES) have limited efficacy due to increased rates of instent‐restenosis, mainly caused by late lumen loss. Drug‐coated balloons (DCB) are a…
read more here.
Keywords:
coated balloons;
drug;
drug coated;
novo lesions ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2019.08.332
Abstract: Use of drug-coated balloon (DCB) in de novo lesions is usually preferred in small vessels, and the recently reported Basket small 2 trial showed that DCBs were noninferior to second-generation DES. All the available data…
read more here.
Keywords:
use sirolimus;
tct 262;
262 use;
novo lesions ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Angiology"
DOI: 10.1177/0003319718809423
Abstract: Managing patients with in-stent restenosis (ISR) remains an important clinical challenge. In particular, large, randomized trials assessing the effect of drug-eluting balloons (DEB) in patients with de novo lesions are warranted. We investigated the effect…
read more here.
Keywords:
drug eluting;
stent restenosis;
isr novo;
eluting stent ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.1017833
Abstract: Background Percutaneous coronary intervention (PCI) has a well-established role in revascularization for coronary artery disease. We performed network meta-analysis to provide evidence on optimal intervention strategies for de novo lesions in small coronary arteries. Materials…
read more here.
Keywords:
novo lesions;
lesions small;
coronary arteries;
analysis ... See more keywords